CFR section

21 CFR 812.150(b)(7): Reports

PART 812-INVESTIGATIONAL DEVICE EXEMPTIONS · Subpart G-Records and Reports

Key facts

Citation 21 CFR 812.150(b)(7)
Section Reports
Part PART 812-INVESTIGATIONAL DEVICE EXEMPTIONS
Subpart Subpart G-Records and Reports
Subchapter 21 CFR H Medical Devices
Product types cited Devices, General
Regulation text (excerpt) (7) Final report. In the case of a significant risk device, the sponsor shall notify FDA within 30 working days of the completion or termination of the investigation and shall submit a final report to FDA and all reviewing the IRB's and participating investigators within 6 months after completion or termination. In the case of a device that is not a significant risk device, the sponsor shall submit a final report to all reviewing IRB's within 6 months after termination or completion.

At a glance

  • 10–99 Inspections citing this section
  • 1–9 Warning letters citing this section

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About CFR sections cited by the FDA

Title 21 of the Code of Federal Regulations contains the FDA's regulations, including current good manufacturing practice and quality system requirements that inspections cite.

Source: U.S. Code of Federal Regulations (eCFR); citation statistics from FDA inspection and warning-letter data

Browse all CFR sections cited by the FDA